BR0313701A - Composição de emulsão-gel tópica compreendendo diclofenaco sódico - Google Patents

Composição de emulsão-gel tópica compreendendo diclofenaco sódico

Info

Publication number
BR0313701A
BR0313701A BR0313701-5A BR0313701A BR0313701A BR 0313701 A BR0313701 A BR 0313701A BR 0313701 A BR0313701 A BR 0313701A BR 0313701 A BR0313701 A BR 0313701A
Authority
BR
Brazil
Prior art keywords
diclofenac sodium
gel composition
emulsion gel
topical emulsion
diclofenac
Prior art date
Application number
BR0313701-5A
Other languages
English (en)
Inventor
Michel Steiger
Original Assignee
Novartis Consumer Health Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31896841&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0313701(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Consumer Health Sa filed Critical Novartis Consumer Health Sa
Publication of BR0313701A publication Critical patent/BR0313701A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO DE EMULSãO-GEL TóPICA COMPREENDENDO DICLOFENACO SóDICO". A presente invenção refere-se a composições farmacêuticas tópicas benéficas compreendendo o sal de diclofenaco sódico em quantidades notavelmente baixas. As referidas composições representam emulsão-géis opacas, em que diclofenaco é mantido totalmente dissolvido.
BR0313701-5A 2002-08-22 2003-08-21 Composição de emulsão-gel tópica compreendendo diclofenaco sódico BR0313701A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02018772 2002-08-22
PCT/EP2003/009302 WO2004017998A2 (en) 2002-08-22 2003-08-21 Topical emulsion- gel composition comprising diclofenac sodium

Publications (1)

Publication Number Publication Date
BR0313701A true BR0313701A (pt) 2005-06-28

Family

ID=31896841

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313701-5A BR0313701A (pt) 2002-08-22 2003-08-21 Composição de emulsão-gel tópica compreendendo diclofenaco sódico

Country Status (16)

Country Link
US (3) US7732489B2 (pt)
EP (1) EP1536836B1 (pt)
AR (1) AR041021A1 (pt)
AT (1) ATE390149T1 (pt)
AU (1) AU2003264086B2 (pt)
BR (1) BR0313701A (pt)
CA (1) CA2496469C (pt)
DE (1) DE60319997T2 (pt)
DK (1) DK1536836T3 (pt)
ES (1) ES2300645T3 (pt)
MX (1) MXPA05002077A (pt)
PE (1) PE20040321A1 (pt)
PT (1) PT1536836E (pt)
SI (1) SI1536836T1 (pt)
TW (1) TWI316857B (pt)
WO (1) WO2004017998A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1588697A1 (en) * 2004-04-16 2005-10-26 Kurt H. Prof. Dr. Bauer Emulsion gel for topical application of pharmaceuticals
FR2882552B1 (fr) * 2005-02-25 2008-12-26 Galderma Sa Gel aqueux de haute stabilite a base de metronidazole et procedes pour leur preparation
EP1919444A2 (en) * 2005-04-27 2008-05-14 Avocet Polymer Technologies, Inc. Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals
EP2076274A4 (en) 2006-09-11 2010-08-04 Biomas Ltd TOPICAL FORMULATIONS OF COMPOUNDS CONTAINING TELLURE
MX2009004038A (es) 2006-10-17 2009-08-24 Nuvo Res Gel de diclofenaco.
GB0704846D0 (en) * 2007-03-13 2007-04-18 Futura Medical Dev Ltd Topical pharmaceutical formulation
DE102007034976A1 (de) 2007-07-26 2009-01-29 Bayer Healthcare Ag Arzneimittel zur transdermalen Anwendung bei Tieren
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US20100099766A1 (en) * 2008-10-16 2010-04-22 Novartis Ag Topical NSAID compositions having sensate component
US20100100060A1 (en) * 2008-10-17 2010-04-22 Novartis Ag Applicator for pharmaceutical product and method of using same
DE102009008094A1 (de) * 2009-02-09 2010-08-19 Barnikol-Keuten, Doris, Dr. In situ Haft-Gelbildende Zubereitungen, insbesondere zur topischen Anwendung auf befeuchtete Haut/Schleimhaut
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
MX2011010547A (es) 2009-04-08 2011-12-16 Cadila Healthcare Ltd Composiciones farmaceuticas estables de diclofenaco.
CA2784827C (en) * 2009-12-16 2018-10-23 Shasun Pharmaceuticals Limited Composition of dexibuprofen transdermal hydrogel
WO2013014680A1 (en) 2011-07-28 2013-01-31 Cadila Healthcare Limited Method for treatment of pain and inflammation
ITMI20121205A1 (it) 2012-07-11 2014-01-12 Glycores 2000 Srl Composizione con attivita' antinfiammatoria ed analgesica da somministrare per uso esterno mediante vaporizzazione
EP2872177B1 (en) 2012-07-12 2017-12-20 Ferring BV Diclofenac formulations
RU2702898C2 (ru) 2014-09-10 2019-10-14 Гск Консьюмер Хелткер С.А. Композиции диклофенака натрия для местного применения
GB201502845D0 (en) * 2015-02-20 2015-04-08 Futura Medical Dev Ltd Topical pharmaceutical formulation
JP6598619B2 (ja) * 2015-09-28 2019-10-30 株式会社ポーラファルマ 物性で特定される皮膚外用剤
FR3064495B1 (fr) * 2017-03-31 2021-04-02 Total Marketing Services Composition a base d'uree pour le traitement des gaz d'echappement
KR20240067245A (ko) 2021-10-01 2024-05-16 뉴트리션 ＆ 바이오사이언시즈 유에스에이 1, 엘엘씨 국소 적용을 위한 하이드로콜로이드 블렌드 조성물
WO2023180792A1 (en) 2022-03-25 2023-09-28 Glycores 2000 Srl Topical pharmaceutical composition with anti-inflammatory and analgesic activity and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH655656B (pt) * 1982-10-07 1986-05-15
US5350769A (en) * 1990-10-30 1994-09-27 Ss Pharmaceutical Co., Ltd. Antiinflammatory gel preparation
EP0592569A1 (en) * 1991-07-03 1994-04-20 Sano Corporation Composition and method for transdermal delivery of diclofenac
US5399342A (en) * 1993-02-03 1995-03-21 Dow Corning Corporation Cosmetics with enhanced durability
KR19990082208A (ko) * 1996-02-07 1999-11-25 오이시 고지 디클로페낙 나트륨의 투명 수용액 및 이를 이용한 의약 조성물
DE69819748T2 (de) * 1997-09-12 2004-09-30 Columbia Laboratories (Bermuda) Ltd. Arzneimittel zur behandlung von dysmenorrhöe und verfrühten wehen
TWI290464B (en) 2000-09-01 2007-12-01 Novartis Consumer Health Sa Treatment of burns
GB0108082D0 (en) 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition

Also Published As

Publication number Publication date
MXPA05002077A (es) 2005-06-08
EP1536836B1 (en) 2008-03-26
US20050239894A1 (en) 2005-10-27
TW200409646A (en) 2004-06-16
US7732489B2 (en) 2010-06-08
US8557870B2 (en) 2013-10-15
PT1536836E (pt) 2008-05-09
DE60319997D1 (de) 2008-05-08
AR041021A1 (es) 2005-04-27
CA2496469C (en) 2011-07-05
AU2003264086A1 (en) 2004-03-11
SI1536836T1 (sl) 2008-08-31
PE20040321A1 (es) 2004-07-15
US20140045942A1 (en) 2014-02-13
CA2496469A1 (en) 2004-03-04
WO2004017998A3 (en) 2004-04-01
DK1536836T3 (da) 2008-07-21
AU2003264086B2 (en) 2007-01-04
ES2300645T3 (es) 2008-06-16
DE60319997T2 (de) 2009-04-30
WO2004017998A2 (en) 2004-03-04
US8716340B2 (en) 2014-05-06
ATE390149T1 (de) 2008-04-15
TWI316857B (en) 2009-11-11
EP1536836A2 (en) 2005-06-08
US20100234462A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
BR0313701A (pt) Composição de emulsão-gel tópica compreendendo diclofenaco sódico
ES2606342T3 (es) Composiciones para el cuidado bucal de sal estannosa y tripoli-fosfato de sodio y métodos
BRPI0412489A (pt) composição de confeito mastigável liberando para as superfìcies dentárias uma dose unitária de uma enzima
BRPI0710485B1 (pt) composições líquidas úteis no tratamento de doenças respiratórias
BRPI0517999A (pt) derivados de tetraidropirano como antidiabéticos
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
ATE484508T1 (de) Furylverbindungen
AR072329A2 (es) Composicion farmaceutica que comprende nateglinida
AR056055A1 (es) Complejos cristalinos e hidratos de 1-cloro-4-(beta-d-glucopiranos-1-il)-2-(4-etinil-bencil)-benceno
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
BRPI0510273A (pt) derivados de tetraazabenzo[e]azuleno e análogos destes
BRPI0410645A (pt) derivados de aril-carbaldeìdo oxima e sua aplicação como agentes estrogênicos
HK1079522A1 (en) Thienyl compounds
BR0114913A (pt) Inibidores de metaloproteinase de espiro-pirimidina-2,4,6-triona
BR0001468A (pt) ácidos dioxiciclopentil hidroxânicos
BRPI0513640A (pt) composição de creme dental opaco e seu método de fabricação
ECSP045441A (es) Nueva sal de perindopril y composiciones farmacéuticas que lo contienen
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
CR9857A (es) Composiciones de suplemento de hierro con tolerancia mejorada
BR0313727A (pt) Derivados de isoquinolina como inibidores de metaloproteinase da matriz
BRPI0017528B8 (pt) uso de uma composição contendo sal de cetotifeno
YU11401A (sh) Lokalne farmaceutske kompozicije koje sadrže nimesulid
BRPI0417166A (pt) composições compreendendo fibra fermentável, adaptadas para uso por um animal de estimação, e kits e métodos para uso das mesmas
BRPI0611526A2 (pt) composição tópica contendo gelatina
BR9908301A (pt) Derivados de indol e composições farmacêuticas que compreendem os mesmos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA.INT.CI. A61K 31/196, A61K 47/06, A61K 47/10, A61K 47/14, A61K 47/32, A61K 9/06, A61K 9/107, A61P 29/00

Ipc: A61K 47/06 (2011.01), A61K 31/196 (2011.01), A61K

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time